StockData
KEQUNasdaqLaboratory Apparatus & FurnitureFiscal year ends April 30

KEWAUNEE SCIENTIFIC CORP /DE/

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$32.10−0.82 (-2.51%)

Close on Oct 19, 2026

Market cap
$93.76M
P/E (TTM)
11.6
Dividend yield
–

About Kewaunee Scientific

Laboratory Apparatus & Furniture, SIC 3821

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. Its product offerings include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin work surfaces and sinks. Following its acquisition of Nu Aire, Inc., the company also supplies airflow products, carbon dioxide incubators, ultralow freezers, animal handling equipment, and pharmacy compounding isolators. Additionally, its international operations offer laboratory facility design, engineering construction, and project management services. Kewaunee serves customers across pharmaceutical, biotechnology, industrial, education, healthcare, and government sectors. It operates through two primary segments: Lab Products Group and International.

Headquartered in Statesville, North Carolina, the company maintains operations in Statesville as well as Plymouth, Minnesota, alongside international subsidiaries in Singapore and India. Kewaunee employs 755 domestic associates and 476 international workers, and it contracts with partners worldwide.

Summary of the business section of Kewaunee Scientific's latest annual report, written by StockData.

Company profile

Company

Legal name
KEWAUNEE SCIENTIFIC CORP /DE/
Founded
1906
Headquarters
Statesville, NC
Address
2700 W Front St 28677
Phone
(704) 873-7202
Industry
Laboratory Apparatus & Furniture
Incorporated in
Delaware
Fiscal year ends
April 30
Auditor
Forvis Mazars, LLP, Raleigh, NC

Stock & identifiers

Ticker
KEQU
Exchange
Nasdaq
Shares outstanding
3M, Sep 8, 2026
Public float
$70.13M, Oct 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
3-for-2, Jan 7, 1985; 3-for-2, Jan 5, 1984
SEC CIK
55529
CUSIP
492854104
ISIN
US4928541048
LEI
549300Z8MHH8NUYXQ229
EIN
38-0715562

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Thomas David Hull IiiPresident & CEO, Director87,388
Ryan S. NobleSVP, Sales & Marketing Dev18,049
Donald T. Gardner IIIChief Financial Officer18,829
Elizabeth D. PhillipsSVP, People & Culture14,904
Douglas J. BatdorffSVP, Manufacturing Operations14,630
Mandar RanadeSVP, IT & Engineering16,215
Keith M. GehlDirector22,409
John Jette CampbellDirector2,703
Margaret B. PyleDirector43,787
John RussellDirector34,396

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026
Mr.Hull
$1.97M$2.81M$795.10K$228–
FY2025
Mr.Hull
$1.81M$1.83M$835.75K$195–
FY2024
Mr.Hull
$2.12M$3.76M$752.32K$220–
FY2023
Mr.Hull
$965.69K$1.07M$554.46K$135–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Corporate history

Events identified from SEC filings